Micro-RNA expression profiling and targeting in peripheral blood in lung cancer
A technology for peripheral blood and lung cancer, applied in biochemical equipment and methods, microbiological determination/testing, anti-tumor drugs, etc., can solve the variability of histological classification, the failure to solve the effectiveness of gene expression and biological correlation, etc. question
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0122] Peripheral whole blood microRNA expression correlated with previously reported primary tumor expression of specific microRNAs.
[0123] The inventors identified miRNAs that were downregulated in both lung tumor and peripheral blood samples from subjects with advanced lung cancer. See Table 1, which shows that miRNAs are altered in the peripheral blood of a group of subjects.
[0124] Table 1 shows decreased and increased miRNAs in lung cancer compared to normal levels in whole blood. Scores (d), fold changes and q-values (%) are shown.
[0125]
[0126]
[0127]
Embodiment 2
[0129] Furthermore, the inventors confirmed the whole peripheral blood expression of a specific miRNA (miR-126) by RT-PCR in the case of non-small cell lung cancer (NSCLC) (n-4) compared to normal controls (n=3) mode (see figure 2 ).
Embodiment 3
[0131] In situ hybridization can be used to identify miRNA localization in mammalian tissues.
[0132] miRNA expression profiling of lung tissue distinguishes lung cancer from normal lung tissue. In situ hybridization studies were used to localize potential miRNAs in human lung cancer tissue samples. In one non-limiting example, miR-155 expression is increased in several solid tumors and hematologic malignancies. In lung cancer, increased miR-155 expression correlates with poor survival.
[0133] However, the localization and regulation of miR-155 expression in lung cancer remains unclear. As shown herein, the immature form of miR-155 has been identified in the nucleus of cancer cells of adenocarcinoma, but the mature form is not easily identified. (see Figure 3A , 3B ).
[0134] While not wishing to be bound by theory, the inventors herein believe that this shows that impaired processing of miR-155 is a possible mechanism of regulation in NSCLC. In bronchoalveolar cel...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com